SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-16-008405
Filing Date
2016-12-08
Accepted
2016-12-08 16:31:42
Documents
11
Period of Report
2016-12-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_120816.htm 8-K 18878
2 PRESENTATION ex99-1.htm EX-99.1 14924
3 GRAPHIC ex99-1_img009.jpg GRAPHIC 143696
4 GRAPHIC ex99-1_img007.jpg GRAPHIC 231060
5 GRAPHIC ex99-1_img008.jpg GRAPHIC 128472
6 GRAPHIC ex99-1_img006.jpg GRAPHIC 286293
7 GRAPHIC ex99-1_img005.jpg GRAPHIC 230708
8 GRAPHIC ex99-1_img004.jpg GRAPHIC 167094
9 GRAPHIC ex99-1_img002.jpg GRAPHIC 393661
10 GRAPHIC ex99-1_img003.jpg GRAPHIC 176688
11 GRAPHIC ex99-1_img001.jpg GRAPHIC 193467
  Complete submission text file 0001387131-16-008405.txt   2723857
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 162041784
SIC: 2834 Pharmaceutical Preparations